NEA Amends GlycoMimetics Stake, Leadership Noted

Ticker: CBIO · Form: SC 13D/A · Filed: Feb 29, 2024 · CIK: 1253689

Glycomimetics INC SC 13D/A Filing Summary
FieldDetail
CompanyGlycomimetics INC (CBIO)
Form TypeSC 13D/A
Filed DateFeb 29, 2024
Risk Levellow
Pages14
Reading Time17 min
Key Dollar Amounts$3.00, $3.35, $3.37
Sentimentneutral

Sentiment: neutral

Topics: insider-ownership, amendment, institutional-investor

TL;DR

**NEA just updated its GlycoMimetics ownership, watch for potential shifts.**

AI Summary

New Enterprise Associates (NEA) filed an SC 13D/A Amendment No. 3 for GlycoMimetics, Inc. on February 29, 2024. The filing updates their beneficial ownership of GlycoMimetics' Common Stock, $.001 par value. Key individuals associated with NEA include Anthony A. Florence, Jr., Mohamad H. Makhzoumi, and Scott D. Sandell, who are part of the NEA 13 GP, LTD and NEA Partners 13, L.P. group members.

Why It Matters

This filing indicates an update to a significant institutional investor's position in GlycoMimetics, which can influence market perception and potentially signal future strategic moves by the company or the investor.

Risk Assessment

Risk Level: low — This is an amendment to a Schedule 13D, indicating a change in beneficial ownership, which is a routine disclosure and not inherently high-risk.

Key Players & Entities

FAQ

What is the purpose of this SC 13D/A filing?

This SC 13D/A filing is Amendment No. 3 to a Schedule 13D, indicating an update to the beneficial ownership information of New Enterprise Associates 10, L.P. regarding GlycoMimetics, Inc.

Who are the key individuals associated with New Enterprise Associates mentioned in this filing?

The key individuals mentioned as group members of New Enterprise Associates are Anthony A. Florence, Jr., Mohamad H. Makhzoumi, and Scott D. Sandell.

What is the CUSIP number for GlycoMimetics, Inc. Common Stock?

The CUSIP number for GlycoMimetics, Inc. Common Stock is 38000Q102.

When was this SC 13D/A filed?

This SC 13D/A was filed on February 29, 2024.

What is the par value of GlycoMimetics, Inc. Common Stock?

The par value of GlycoMimetics, Inc. Common Stock is $.001.

Filing Stats: 4,255 words · 17 min read · ~14 pages · Grade level 8.4 · Accepted 2024-02-29 19:28:30

Key Financial Figures

Filing Documents

From the Filing

SC 13D/A 1 nea10-glyco_18804.htm NEW ENTERPRISE ASSOCIATES 10, L.P. / GLYCOMIMETICS -- SCHEDULE 13D/A(#3) Schedule 13D UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* GlycoMimetics, Inc. (Name of Issuer) Common Stock, $.001 par value (Title of Class of Securities) 38000Q102 (CUSIP Number) Stephanie Brecher New Enterprise Associates 1954 Greenspring Drive, Suite 600, Timonium, MD 21093 (410) 842-4000 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) February 6, 2024 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Note : Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No.38000Q102 13D Page 2 of 18 Pages 1. NAMES OF REPORTING PERSONS. New Enterprise Associates 10, Limited Partnership 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) (b) 3. SEC USE ONLY 4. SOURCE OF FUNDS (see instructions) WC 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7. SOLE VOTING POWER 0 Shares 8. SHARED VOTING POWER 4,007,977 Shares 9. SOLE DISPOSITIVE POWER 0 Shares 10. SHARED DISPOSITIVE POWER 4,007,977 Shares 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,007,977 Shares 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 6.2% 14. TYPE OF REPORTING PERSON (see instructions) PN CUSIP No.38000Q102 13D Page 3 of 18 Pages 1. NAMES OF REPORTING PERSONS. NEA Partners 10, Limited Partnership 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) (b) 3. SEC USE ONLY 4. SOURCE OF FUNDS (see instructions) AF 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7. SOLE VOTING POWER 0 Shares 8. SHARED VOTING POWER 4,007,977 Shares 9. SOLE DISPOSITIVE POWER 0 Shares 10. SHARED DISPOSITIVE POWER 4,007,977 Shares 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,007,977 Shares 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 6.2% 14. TYPE OF REPORTING PERSON (see instructions) PN CUSIP No.38000Q102 13D Page 4 of 18 Pages 1. NAMES OF REPORTING PERSONS. New Enterprise Associates 13, L.P. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) (b) 3. SEC USE ONLY 4. SOURCE OF FUNDS (see instructions) WC 5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6. CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7. SOLE VOTING POWER 0 Shares 8. SHARED VOTING POWER 4,007,977 Shares 9. SOLE DISPOSITIVE POWER 0 Shares 10. SHARED DISPOSITIVE POWER 4,007,977 Shares 11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 4,007,977 Shares 12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) 13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 6.2% 14. TYPE OF REPORTING PERSON (see instructions) PN CUSIP No.38000Q102 13D Page 5 of 18 Pages 1. NAMES OF REPORTING PERSONS. NEA Partners 13, L.P. 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) (b) 3. SEC USE ONLY 4. SOURCE OF FUNDS (see instructions) AF 5. CHEC

View Full Filing

View this SC 13D/A filing on SEC EDGAR

View on Read The Filing